Division of Gastroenterology, Nippon Medical School, Tokyo, Japan.
Department of Gastroenterology and Hepatology, Yokohama City Univeristy, Yokohama, Japan.
J Gastroenterol Hepatol. 2022 Aug;37(8):1525-1533. doi: 10.1111/jgh.15874. Epub 2022 May 11.
To clarify whether there were any significant differences in clinical symptoms and eating patterns between functional dyspepsia (FD) patients and FD with pancreatic enzyme abnormalities (FD-P) patients as refractory FD, we compared these factors in multicenter studies in Singapore and Japan.
One hundred ninety-eight consecutive patients presenting with FD (n = 88), FD-P patients (n = 81) based on Rome III classification and controlled group (n = 39) recruited from six institutions in Singapore and Japan. Clinical characteristics, clinical symptoms for dietary fat intake, and eating behaviors were estimated using questionnaires. Anxiety and health-related quality of life were determined by STAI-state/-trait and SF-8, respectively.
There were no significant differences in age, sex, BMI, smoking, alcohol intake, past medical history, and history of allergy in FD and FD-P patients between Singapore and Japan. There were no significant differences in FD subtypes, gastrointestinal symptom rating scale score, severity of FD symptoms, and eating pattern in Singapore and Japan. Moreover, there were significant differences in certain eating behaviors between FD and FD-P patients in Singapore and Japan. Interestingly, epigastric pain and early satiety following fat meals in FD-P patients were significantly (P = 0.003 and P = 0.008, respectively) higher compared with those in FD patients in Japan. Physical component score in FD-P patients was significantly (P = 0.019) disturbed compared with those in FD patients in Japan.
Epigastric pain and early satiety following fat meals in FD-P patients may be useful tools to differentiate FD-P patients from FD patients in Japan.
为明确功能性消化不良(FD)患者与胰腺外分泌功能不全相关 FD(FD-P)患者作为难治性 FD 是否存在临床症状和进食模式的显著差异,我们在新加坡和日本的多中心研究中对此进行了比较。
纳入 198 例连续就诊的 FD(n=88)、FD-P 患者(n=81),均基于 Rome III 分类,以及来自新加坡和日本 6 家机构的对照组(n=39)。采用问卷调查评估临床特征、脂肪摄入相关的临床症状和进食行为,采用 STAI-state/-trait 和 SF-8 评估焦虑和健康相关生活质量。
新加坡和日本 FD 和 FD-P 患者的年龄、性别、BMI、吸烟、饮酒、既往病史和过敏史无显著差异。新加坡和日本 FD 亚型、胃肠道症状评分量表评分、FD 症状严重程度和进食模式无显著差异。此外,新加坡和日本 FD 和 FD-P 患者之间存在某些进食行为的显著差异。有趣的是,FD-P 患者餐后上腹疼痛和早饱显著高于 FD 患者(P=0.003 和 P=0.008)。FD-P 患者的生理成分评分明显低于 FD 患者(P=0.019)。
FD-P 患者餐后上腹疼痛和早饱可能是日本 FD-P 患者与 FD 患者鉴别的有用工具。